Endo Confirms $10.6B Salix Bid, Besting Valeant Offer
Valeant Pharmaceuticals International Inc. is apparently headed for another big-ticket takeover battle after rival Endo Pharmaceuticals Inc. on Wednesday leveled a $10.6 billion cash-and-stock offer for Salix Pharmaceuticals Ltd., the company...To view the full article, register now.
Already a subscriber? Click here to view full article